DEA vs DOC

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 16, 2026

DEA

58.0
AI Score
VS
DEA Wins

DOC

53.9
AI Score

Investment Advisor Scores

DEA

58score
Recommendation
HOLD

DOC

54score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric DEA DOC Winner
Forward P/E 74.6269 169.4915 DEA
PEG Ratio 0 4.0809 Tie
Revenue Growth 9.2% 11.1% DOC
Earnings Growth -31.3% 68.2% DOC
Tradestie Score 58.0/100 53.9/100 DEA
Profit Margin 2.8% 8.2% DOC
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

DEA 1M: -4.3% · 3M: +2.0% DOC 1M: +0.3% · 3M: +5.7%

Current Technical Phase

DEA

Markdown
Sell / avoid

Price below a falling SMA50 (slope -0.1%), weak momentum, RSI 32

RSI (14): 32.2 · Price: $23.44

DOC

Markdown
Sell / avoid

Price below a falling SMA50 (slope -0.1%), weak momentum, RSI 43

RSI (14): 43.5 · Price: $20.51

Fundamentals Snapshot

Metric DEA DOC
Market Cap
Forward P/E 76.6 146.4
Trailing P/E 122.6 58.1
Revenue (TTM)
Revenue Growth 0.1% 0.1%
Gross Margin 0.7% 0.6%
Operating Margin 0.3% 0.2%
EPS 0.19 0.35
Dividend Yield 0.08% 0.06%

Frequently Asked Questions

Based on our detailed analysis, DEA is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.